ArticleHuman vaccines & immunotherapeutics2023

How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be?

Ru Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.